Portal Access secures $7M for chemotherapy port

The company will use the funds to support a 510(k) submission to the FDA for its Flexi-Port SLF-TANL for oncology patients.

May 30, 2025 - 14:44
 0
Portal Access secures $7M for chemotherapy port
The company will use the funds to support a 510(k) submission to the FDA for its Flexi-Port SLF-TANL for oncology patients.